Table 1.
Authors | Year of Publication | Virus | Separation Used | Targeted or Untargeted Identification | Mass Spec. Strategy |
---|---|---|---|---|---|
Davison et Davison [8] | 1995 | CCV | Gel based | Targeted | Peptide mass fingerprint |
Nealon et al. [13] | 2001 | KSHV | Gel based | Targeted | LC MS/MS |
Bortz et al. [14] | 2003 | MHV6 | Gel based | Targeted | LC MS/MS |
Varnum et al. [15] | 2004 | HCMV | Gel free (2D) | Untargeted | LC MS/MS |
Johannsen et al. [16] | 2004 | EBV | Gel based | Untargeted | LC MS/MS |
Kattenhorn et al. [17] | 2004 | MCMV | Gel based | Targeted | LC MS/MS |
Bechtel et al. [18] | 2005 | KSHV | Gel based | Targeted | MS/MS (Maldi Tof/Tof) |
Zhu et al. [19] | 2005 | KSHV | Gel based | Targeted | LC MS/MS |
O’connor et al. [20] | 2006 | RRV | Gel free + Gel based | Untargeted | LC MS/MS |
Michael et al. [21] | 2006 | PRV | Gel based (1D + 2D) | Targeted | Peptide mass fingerprint |
Loret et al. [22] | 2008 | HSV-1 | Gel based | Targeted | LC MS/MS |
Dry et al. [23] | 2008 | AlHV1 | Gel based | Untargeted | LC MS/MS |
Kunec et al. [24] | 2009 | CCV | Gel free (2D) | Untargeted | LC MS/MS |
Michel et al. [25] | 2010 | CyHV-3 | Gel based + Gel free (2D) | Untargeted | LC MS/MS |
Kramer et al. [26] | 2011 | PRV | Gel based + Gel free | Untargeted | Maldi + ESI MS/MS |
Van Beurden et al. [27] | 2011 | AngHV-1 | Gel based + Gel free (2D) | Untargeted | LC MS/MS |
Lété et al. [28] | 2012 | BoHV-4 | Gel based + Gel free (2D) | Untargeted | LC MS/MS |
Vidick et al. [29] | 2013 | MuHV-4 | Gel based | Untargeted | LC MS/MS |
CCV: canine coronavirus; KSHV: Kaposi’s sarcoma-associated herpesvirus; MHV6: murine hepatitis virus; HCMV: human cytomegalovirus; EBV: Epstein–Barr virus; MCMV: mouse cytomegalovirus; RRV: Ross River virus; PRV: pseudorabies virus; HSV-1: herpes simplex virus type 1; AIHV1: Alcelaphine herpesvirus 1; CyHV-3: Cyprinid herpesvirus 3; AngHV-1: Anguillid herpesvirus 1; BoHV-4: Bovine herpesvirus 4; MuHV4: Murid herpesvirus 4.